|
Digital XP Panel 01 Digital XP Panel 01 - A Primer on Clinical Trial Design to Interpret and Translate Findings to Patient Care
|
1.25 |
|
|
|
|
PRO 01 PRO Re-Irradiation
|
1.25 |
|
|
|
|
PRO 02 (INTERACTIVE) PRO: RO Model, Quality Program and Socioeconomic Updates for 2022
|
1.25 |
|
|
|
|
PRO 03 Central Nervous System: Case Based Discussion
|
1.25 |
|
|
|
|
PRO 04 Lung Cancer: Case Based Discussion
|
1.25 |
|
|
|
|
PRO 05 ASTRO PRO Session - Prostate Oligometastases Panel Discussion
|
1.25 |
|
|
|
|
PRO 06 (INTERACTIVE) Practical Radiation Oncology: Gastrointestinal Cancer Session
|
1.25 |
|
|
|
|
International 01 Latin American ASTRO
|
3.25 |
|
|
|
|
PRO 07 (INTERACTIVE) PRO Update on GYN: Case Studies, Updates and "Soup to Nuts" Discussion of Intermediate to Advanced Cervical and Endometrial Cancer
|
1.25 |
|
|
|
|
Digital XP eCon 01 eContouring for Gastrointestinal Cancer
|
1.25 |
|
|
|
|
Panel 04 (Live SA-CME) Challenging Cases in Breast Cancer
|
1.25 |
|
|
|
|
Panel 03 (INTERACTIVE) Palliative Radiotherapy in Pediatric Patients - What Can We Learn From Adult-Derived Evidence-
|
1.25 |
|
|
|
|
EDU 01 Multidisciplinary Management of Very High Risk to Oligometastatic Prostate Cancer
|
1.25 |
|
|
|
|
Panel 01 (Live SA-CME) Challenging Cases in Cervix Cancer
|
1.25 |
|
|
|
|
EDU 03 Updates on Brain Stereotactic Radiosurgery for Benign Conditions
|
1.25 |
|
|
|
|
EDU 02 ASTRO/NCI Diversity Symposium - Physician Driven Social Change: A Historical Perspective and Opportunities for Radiation Oncologists
|
1.25 |
|
|
|
|
International 03 Bridging the Gap: Highlighting Efforts to Build Radiation Oncology Capacity Globally
|
1.25 |
|
|
|
|
Panel 05 Professional Chameleons: Embracing New Roles in Medical Physics to Advance Person-Centered Care
|
1.25 |
|
|
|
|
Joint 01 Joint 01 - ASTRO/Radiosurgery Society Joint Session - Heterogeneous Tumor Dose and Spatial Fractionated Radiation Therapy: Clinical Results Begin to Confirm Preclinical Concepts
|
1.25 |
|
|
|
|
PRO 08 Practical Radiation Oncology - Breast Cancer Session
|
1.25 |
|
|
|
|
PRO 09 (INTERACTIVE) Intermediate Risk Prostate Cancer: From Consult Through Follow Up
|
1.25 |
|
|
|
|
Digital XP Panel 02 Digital XP Panel 02 - Managing Radiotherapy-Induced Symptoms; Practical Evidence-Based Strategies for the Radiation Oncologist
|
1.25 |
|
|
|
|
PRO 10 (Live SA-CME) Management of a Tonsil Cancer Patient: From Work-up Through Late Radiation Toxicity
|
1.25 |
|
|
|
|
SS 01 Breast 1 - Techniques and Toxicity
|
1.25 |
|
|
|
|
QP 02 CNS 2 - Brain Response to Radiation and Other Topics
|
1 |
|
|
|
|
QP 03 GI 2 - Bugs and Drugs but No Humbugs in GI Radiotherapy
|
1 |
|
|
|
|
QP 04 Hem 2 - The Evolving Role of Radiation in Indolent Lymphomas
|
1 |
|
|
|
|
SS 02 Lung 1 - Integration of Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer
|
1.25 |
|
|
|
|
SS 03 Bio 1 - Genomic and Molecular Biomarkers
|
1.25 |
|
|
|
|
QP 01 Phys 6 - Imaging Technology and Applications
|
1 |
|
|
|
|
International 02 ASTRO/ESTRO Joint Session - Spatially Fractionated Radiotherapy-Techniques and Benefits
|
1.25 |
|
|
|
|
CT 01 Clinical Trials and Innovation
|
1.5 |
|
|
|
|
Presidential Symposium Introduct Presidential Symposium: Advancing Person Centered Care Through Innovation - Introduction
|
0.25 |
|
|
|
|
PS 01 Presidential Symposium: Session I - Harnessing Scientific Innovation to Improve Person-Centered Care
|
1.25 |
|
|
|
|
PS 02 Presidential Symposium: Session II - Digital Health to Improve Patient Outcomes and Experience
|
1 |
|
|
|
|
PS 03 Presidential Symposium: Session III - Aiming to Improve Patient Outcomes with Paradigm Changing Applications of Radiotherapy
|
1 |
|
|
|
|
PS 04 Presidential Symposium: Session IV - Debate: Randomized Clinical Trials vs. Real World Data
|
1 |
|
|
|
|
Digital XP ST 01 Digital XP Storytelling 01 - Resilience and Self-Care: From Peer to Peer
|
0.5 |
|
|
|
|
International 05 (INTERACTIVE) Joint ASTRO-RUSSCO Session: "Medice, cura aegrotum, sed non morbum": Emotional and Mental Health of Cancer Patients Undergoing Treatment
|
1.25 |
|
|
|
|
EDU 07 (INTERACTIVE) Quality Payment Program Update
|
1.25 |
|
|
|
|
EDU 08 2022 Radiation Oncology Coding and Coverage Update
|
1.25 |
|
|
|
|
EDU 04 (Live SA-CME) Radiation Oncologists' Role in Promoting Person-Centered Care in the Curative and Palliative Settings
|
1 |
|
|
|
|
Panel 10 (INTERACTIVE) Mitigating Bias in Recruitment: Attracting a Diverse, Dynamic Workforce to Sustain the Future of Radiation Oncology
|
1.25 |
|
|
|
|
EDU 05 (INTERACTIVE) Improving Quality of Life and Outcomes for Patients With Upper GI Cancers With Advancements in Treatment Technology
|
1 |
|
|
|
|
Joint 02 (Live SA-CME) ASTRO/IOTN Joint Session - Radiation/Immunotherapy Combinations - Clinical Highlights and Case Discussion
|
1.25 |
|
|
|
|
Special Session 02 (INTERACTIVE) Paint by MRI: A New Era in Biologically-Driven Adaptive Radiotherapy
|
1 |
|
|
|
|
EDU 06 Radiation in the Multidisciplinary Management of Thymic Malignancies
|
1.25 |
|
|
|
|
Panel 09 PENTEC: Pediatric Normal Tissue Effects in the Clinic: An international Collaboration - Task Force Results, Knowledge Gaps, and the Path Forward
|
1.25 |
|
|
|
|
Panel 07 Quantitative Imaging for Support of Radiation Oncology-Focused Clinical Trials in the US and Abroad
|
1.25 |
|
|
|
|
EDU 10 (Live SA-CME) Debating the Best Treatment for Early Prostate Cancer: Surgery, Radiation, or Neither
|
1 |
|
|
|
|
EDU 09 The New Virtual Reality: Improving Care Through Telemedicine and Understanding Its Impact on Patients, Policy, and Payment
|
1.25 |
|
|
|
|
EDU 12 Innovative Biologic Approaches to Personalize RT for Metastatic Breast Cancer
|
1 |
|
|
|
|
EDU 11 Creating Equitable and Inclusive Spaces for Black, Indigenous, and Latinx Trainees, Residents, and Faculty: Opportunities and Pathways
|
1 |
|
|
|
|
Panel 08 AI-Empowered Clinical Decision Support for Better Treatment Outcomes
|
1.25 |
|
|
|
|
International 04 Novel Educational Opportunities in the IT-Enabled World
|
1 |
|
|
|
|
Panel 06 ASTRO's First Evidence-Based Guideline on Soft Tissue Sarcoma in Adults: Case-Based Implementation of Recommendations
|
1.25 |
|
|
|
|
QP 05 Breast 3 - Breast Cancer: Quick Pitch
|
1 |
|
|
|
|
SS 07 CNS 1 - Clinical Trials and Novel Approaches to Malignant Brain Tumors
|
1.25 |
|
|
|
|
QP 07 DHI 2 - Evolution of Machine Learning Guided Decision Frameworks in Clinical Practice and Research
|
1 |
|
|
|
|
SS 08 DEIH 1 - Diversity, Equity and Inclusion in Healthcare
|
1.25 |
|
|
|
|
SS 11 GI 1 - Trust but Verify: Quality Assurance and Quality of Life in GI Cancers
|
1.25 |
|
|
|
|
SS 05 GYN 1 - Advancements in Gynecological Treatment in the Era of Personalized Medicine
|
1 |
|
|
|
|
SS 10 H&N 1 - Improving Outcomes for Head and Neck Cancer Patients
|
1.25 |
|
|
|
|
QP 09 HSR 2 - Global Oncology
|
1 |
|
|
|
|
QP 11 Lung 3 - Cardiac Dose Effects in Locally Advanced Lung Cancer Patients
|
1 |
|
|
|
|
QP 08 Palliative 2 - Improving Symptoms Through Supportive Care and Palliative Radiotherapy
|
1 |
|
|
|
|
QP 06 Patient Safety 2 - Communication, Telehealth and Safety in a Pandemic and Beyond
|
1 |
|
|
|
|
SS 12 Sarcoma 1 - Individualization of Radiotherapy Based Treatment for Sarcoma and Cutaneous Malignancy
|
1 |
|
|
|
|
QP 10 Bio 5 - Immunotherapy, Immune Response and Inflammation II
|
1 |
|
|
|
|
QP 12 Bio 6 - Normal Tissue Injury
|
1 |
|
|
|
|
SS 06 Phys 1 - Best of Physics
|
1.25 |
|
|
|
|
SS 09 Phys 2 - Ultra-High Dose Rate Radiotherapy (FLASH)
|
1.25 |
|
|
|
|
SS 04 Phys 4 - Imaging for Response Assessment
|
1 |
|
|
|
|
SS 13 DHI 3 - The U-Net & You: Is Segmentation a Solved Problem-
|
1 |
|
|
|
|
PL 01 Plenary Session
|
1.5 |
|
|
|
|
Keynote Address 01 Moral Injury and Choosing Change
|
1 |
|
|
|
|
Special Session 01 (INTERACTIVE) The Science of Hope: Why and How To Approach the Most Difficult Situations in Oncology
|
1.25 |
|
|
|
|
Presidential Address The Time for Change is Now
|
0.5 |
|
|
|
|
ST 01 Storytelling 1 - Parental Leave: Navigating the Pressures of Starting a Family and Radiation Oncology Practice and/or Training
|
1 |
|
|
|
|
SH 01 Science Highlights 1 - Genitourinary Cancer
|
0.5 |
|
|
|
|
SH 02 Science Highlights 2 - Diversity, Equity, and Inclusion in Healthcare
|
0.5 |
|
|
|
|
Digital XP eCon 02 eContouring for Oligometastatic Disease
|
1.25 |
|
|
|
|
Digital XP EDU 01 Digital XP SA-CME: EDU 01 - Patient Focused Treatment of Gynecologic Cancers
|
1.25 |
|
|
|
|
Digital XP ST 02 Digital XP Storytelling 02 - Beneath the Treatment Mask: The mess that mortality makes of the mind
|
0.5 |
|
|
|
|
Digital XP SH 07 Digital XP Science Highlights 07 - Breast
|
0.5 |
|
|
|
|
Digital XP SH 09 Digital XP Science Highlights 09 - Digital Health Innovation
|
0.5 |
|
|
|
|
Digital XP SH 08 Digital XP Science Highlights 08 - Biology
|
0.5 |
|
|
|
|
Digital XP SH 10 Digital XP Science Highlights 10 - Health Services Research
|
0.5 |
|
|
|
|
Digital XP SH 11 Digital XP Science Highlights 11 - Palliative
|
0.5 |
|
|
|
|
Digital XP SH 12 Digital XP Science Highlights 12 - Patient Reported Outcomes
|
0.5 |
|
|
|
|
Digital XP SH 13 Digital XP Science Highlights 13 - Patient Safety
|
0.5 |
|
|
|
|
Digital XP SH 14 Digital XP Science Highlights 14 - Pediatrics
|
0.5 |
|
|
|
|
Panel 15 (INTERACTIVE) Challenging Cases in GU Malignancies
|
1.25 |
|
|
|
|
SS 19 Palliative 1 - Improving Outcomes and Selection of Patients for SBRT in the Oligometastatic Setting and Beyond
|
1.25 |
|
|
|
|
EDU 18 (INTERACTIVE) Priming the Immune System Prior to CAR T Cell Therapy: An Emerging Role of Radiation
|
1.25 |
|
|
|
|
Panel 11 Warning: The COVID-19 Pandemic May Be - IS Hazardous to Your Mental Health
|
1.25 |
|
|
|
|
EDU 13 (INTERACTIVE) Radiotherapy Options for Early Stage Breast Cancer: How to Select the "Best" Regimen Among an Increasing Array of Options and the Implications for Patients and Practices
|
1 |
|
|
|
|
Joint 03 ASTRO/SPRO Joint Session - Challenging Cases in Palliative Care
|
1 |
|
|
|
|
Panel 14 Clinical Translation of FLASH Radiotherapy
|
1.25 |
|
|
|
|
EDU 14 (Live SA-CME) Challenging Cases in GI Malignancies
|
1 |
|
|
|
|
Panel 27 Judicious Use of SRS and HSRT in the Management of Limited Large Brain Metastases
|
1.25 |
|
|
|
|
EDU 16 (INTERACTIVE) Novel Radiotherapy Approaches in Stage IV NSCLC: Consolidation, Oligometastases, and Oligorecurrences
|
1.25 |
|
|
|
|
Panel 13 Real-World Data and Real-World Evidence in Radiation Oncology: An ASTRO-ASCO Jointly Sponsored Session
|
1.25 |
|
|
|
|
EDU 17 Leveraging the Power of Radiation Therapy to Modulate Anti-Tumor Immunity
|
1.25 |
|
|
|
|
Panel 16 (Live SA-CME) ASTRO's First Evidence-Based Clinical Practice Guidelines on Radiation Therapy for Primary Liver Cancers
|
1.25 |
|
|
|
|
Panel 17 (INTERACTIVE) Challenging Cases in Patient Safety: Leveraging RO-ILS Events to Improve Patient Treatment and Experience
|
1.25 |
|
|
|
|
EDU 15 Hypoxia: Back in the Spotlight
|
1 |
|
|
|
|
Panel 12 (Live SA-CME) Recent Developments in the Prediction of Clinical Outcomes Data in Radiation Oncology
|
1.25 |
|
|
|
|
SS 21 Breast 2 - Biology and Outcomes
|
1.25 |
|
|
|
|
SS 20 DHI 1 - Clinical Applications of Big Data Informatics and Machine Learning
|
1.25 |
|
|
|
|
SS 15 GU 1 - Biomarkers and Salvage RT
|
1 |
|
|
|
|
QP 14 GU 3 - GU Smorgasbord
|
1 |
|
|
|
|
QP 15 GYN 2 - Clinical Innovation in Gynecologic Cancers
|
1 |
|
|
|
|
QP 13 Hem 3 - Pulling the Chestnut Out of the Fire: Treating Relapsed Lymphoma
|
1 |
|
|
|
|
SS 18 Bio 2 - Experimental Therapeutics
|
1.25 |
|
|
|
|
SS 22 Bio 3 - Immunotherapy, Immune Response and Inflammation
|
1.25 |
|
|
|
|
SS 17 Phys 3 - Novel Planning and Treatment Techniques
|
1.25 |
|
|
|
|
SS 14 Phys 5 - Image Guidance and Motion Management
|
1 |
|
|
|
|
Keynote Address 02 The Choices that Matter
|
1 |
|
|
|
|
Special Session 04 ASTRO/SNMMI Joint Session - Prostate Cancer Molecular Imaging and Radiotheranostics
|
1.25 |
|
|
|
|
SH 03 Science Highlights 3 - Head and Neck Cancer
|
0.5 |
|
|
|
|
SH 04 Science Highlights 4 - Gynecologic Cancer
|
0.5 |
|
|
|
|
Digital XP eCon 03 eContouring for Gynecologic Cancer
|
1.25 |
|
|
|
|
Digital XP Keynote Illuminating the Dark Space of Healthcare with Ambient Intelligence
|
1 |
|
|
|
|
Digital XP SH 15 Digital XP Science Highlights 15 - Sarcoma
|
0.5 |
|
|
|
|
Digital XP SH 16 Digital XP Science Highlights 16 - CNS
|
0.5 |
|
|
|
|
Digital XP ST 03 Digital XP Storytelling 03 -What Happens When Physicists Get Involved In Direct Patient Care-
|
0.5 |
|
|
|
|
Panel 20 Molecular Biomarkers and Tumor-Free DNA in HPV-Associated Oropharyngeal Cancer and Implications for Future Clinical Trials
|
1.25 |
|
|
|
|
EDU 24 Transforming Radiation Therapy for Lymphomas in 2021: Embracing Change to Achieve More Comfort, More Safety, and Better Outcomes
|
1.25 |
|
|
|
|
Joint 04 (INTERACTIVE) ASTRO/Society for Neuro-Oncology Joint Session - Glioma Controversies: Patient-Focused Case-Based Discussion
|
1.25 |
|
|
|
|
Panel 28 Adaptive Radiation Therapy With Artificial Intelligence: The Emerging Technologies and Clinical Translation
|
1.25 |
|
|
|
|
EDU 19 (INTERACTIVE) Practical Management of Vulvar and Vaginal Cancers: Standard and Challenging Scenarios
|
1 |
|
|
|
|
EDU 22 How to Manage the Complex Needs of Pelvic Radiotherapy Survivors
|
1 |
|
|
|
|
EDU 21 Biological Intelligence in Oligometastases: Are We There Yet-
|
1 |
|
|
|
|
Panel 22 From Art to Science - The Rise of Automation in Treatment Planning
|
1.25 |
|
|
|
|
EDU 23 Optimizing the Use of Patient-Reported Outcomes in Research and Practice
|
1.25 |
|
|
|
|
Panel 25 Why We Disagree: Clinical Trial Interpretation and Philosophies From Frequentist, Bayesian, and AI Perspectives
|
1.25 |
|
|
|
|
Panel 24 Exploring mHealth and Wearables in Oncology: Opportunities and Challenges
|
1.25 |
|
|
|
|
Panel 26 Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists
|
1.25 |
|
|
|
|
Panel 19 (Live SA-CME) Difficult Cases in Small Cell Lung Cancer
|
1.25 |
|
|
|
|
EDU 25 (INTERACTIVE) Updates in Locoregional Skin Cancer Management
|
1.25 |
|
|
|
|
Panel 21 Advances in Image-Guided Adaptive Radiotherapy
|
1.25 |
|
|
|
|
EDU 26 Radiation, Autophagy, and Senescence in Tumor Response: Mechanisms and Clinical Implications
|
1.25 |
|
|
|
|
QP 17 GI 3 - Where Are We Going With Pancreatic Cancer Radiotherapy- Novel Biomarkers and Dosing Strategies
|
1 |
|
|
|
|
SS 25 GU 2 - Intermediate and High Risk Disease
|
1.25 |
|
|
|
|
QP 18 H&N 2 - Head and Neck Cancer in 2021: Updates and New Directions
|
1 |
|
|
|
|
SS 23 HSR 1 - Best of Health Services Research
|
1 |
|
|
|
|
SS 26 Hem 1 - Enhancing Efficacy and Reducing Toxicity for Patients With Hematologic Malignancies
|
1.25 |
|
|
|
|
SS 30 Lung 2 - Individualized Radiotherapy Approaches for Lung Cancer
|
1.25 |
|
|
|
|
SS 24 Patient Reported Outcomes 1 - The Heart of Person Centered Care
|
1 |
|
|
|
|
SS 29 Patient Safety 1 - How to Stay Calm and Carry On in a Pandemic
|
1.25 |
|
|
|
|
SS 27 Peds 1 - Improving the Therapeutic Ratio in Pediatric Malignancies
|
1.25 |
|
|
|
|
SS 28 Bio 4 - Cancer Biology
|
1.25 |
|
|
|
|
QP 16 Phys 7 - Dose Response Analysis and Novel Treatment Technology
|
1 |
|
|
|
|
ST 02 Storytelling 02 - Promoting Women and Underrepresented Minorities as Essential Leaders of Research
|
1 |
|
|
|
|
SH 05 Science Highlights 5 - Lung Cancer
|
0.5 |
|
|
|
|
SH 06 Science Highlights 6 - Gastrointestinal Cancer
|
0.5 |
|
|
|
|
CB 01 Cancer Breakthroughs
|
1 |
|
|
|
|
Digital XP EDU 02 Digital XP SA-CME: EDU 02 - Integration of Surgery in the Multidisciplinary Care of Head and Neck Cancer: Focus on Oral Cavity, Larynx, and Hypopharynx Cancers
|
1.25 |
|
|
|
|
Digital XP ST 04 Digital XP Storytelling 04 - Endpoints-PRO That matters to Patients
|
0.5 |
|
|
|
|
Digital XP SH 17 Digital XP Science Highlights 17 - Hematologic Cancers
|
0.5 |
|
|
|
|
Digital XP SH 18 Digital XP Science Highlights - Physics
|
0.5 |
|
|
|